This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Conjunctiva
CD2_BENIGN_CONJUNCTIVA_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum conjunctivae
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Conjunctiva
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Conjunctiva
- Benign neoplasm of eye and adnexa
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1168 | 687 | 481 |
| Unadjusted period prevalence (%) | 0.23 | 0.23 | 0.21 |
| Median age at first event (years) | 53.42 | 50.89 | 57.03 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1037
- Matched controls
- 10368
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
4503599627370496.0
323.0
907
*
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
990.1
309.1
288
*
CFA20
NOMESCO Finland
Biopsy of conjunctiva
344.2
122.0
121
*
22400
ICD-8 Finland
Benign neoplasm of eye, Conjunctivae
+∞
97.4
92
*
XCK10
NOMESCO Finland
Photography of fundus of eye
5.0
60.6
219
531
115
Kela drug reimbursment
Breast cancer
+∞
60.0
57
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
11.4
58.9
114
111
C61
ICD-10 Finland
Malignant neoplasm of prostate
577.9
56.1
55
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
54.7
52
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
9.3
52.2
113
135
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
51.5
49
*
130
Kela drug reimbursment
Malignant tumour
+∞
45.1
43
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
98.4
43.1
47
5
H02AB02
ATC
dexamethasone; systemic
16.6
41.4
67
43
2243A
ICD-9 Finland
Benign neoplasm of eye, Conjunctiva
+∞
40.9
39
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.4
36.9
491
2858
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
35.6
34
*
CBA10
NOMESCO Finland
Biopsy of eyelid
24.9
35.6
50
21
A04AA02
ATC
granisetron; systemic, transdermal
120.6
32.9
35
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
32.5
31
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
49.2
31.7
38
8
WF002
NOMESCO Finland
Radical radiotherapy
54.7
31.5
37
7
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
322.1
31.0
31
*
HAC20
NOMESCO Finland
Total mastectomy
113.5
30.8
33
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
39.4
30.4
38
10
116
Kela drug reimbursment
Prostate cancer
+∞
30.4
29
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.2
29.6
408
2343
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
29.3
28
*
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
28.2
27
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
25.1
24
*
H00.1
ICD-10 Finland
Chalazion
5.5
24.2
73
140
A03FA01
ATC
metoclopramide; systemic, rectal
2.8
24.1
172
688
HAB40
NOMESCO Finland
Wedge excision of mammary gland
23.4
24.0
34
15
L03AA13
ATC
pegfilgrastim; parenteral
+∞
23.0
22
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.4
22.8
216
1012
L02BA01
ATC
tamoxifen; oral
85.4
22.7
25
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
21.9
21
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
21.9
21
*
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
20.6
21.8
32
16
ZXA00
NOMESCO Finland
Right side
2.1
21.1
297
1665
JN4BD
NOMESCO Finland
Extensive body CT
4.1
20.2
80
205
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
19.8
19
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
203.7
19.6
20
*
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
16.2
18.9
30
19
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
193.3
18.6
19
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.6
18.6
66
152
H04.10
ICD-10 Finland
Dry eye syndrome
2.7
18.2
133
536
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
18.0
288
1685
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
17.8
17
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
17.8
17
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
17.8
17
*
L01BC06
ATC
capecitabine; oral
+∞
17.8
17
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
16.7
16
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
16.7
16
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
172.6
16.5
17
*
ZXA05
NOMESCO Finland
Left side
1.9
15.7
258
1512
Y77
ICPC
Malignant neoplasm prostate
+∞
15.7
15
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
86.4
15.6
17
*
S18
ICPC
Laceration/cut
1.7
15.1
402
2765
HA1AA
NOMESCO Finland
X-ray mammography
4.6
15.0
52
118
F29
ICPC
Eye symptom/complaint other
2.7
14.9
104
407
L02BG04
ATC
letrozole; oral
7.6
14.8
34
46
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
14.7
254
1513
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.8
14.6
49
107
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
14.6
14
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
14.6
14
*
WX002
NOMESCO Finland
Sedation and analgesia
2.0
14.6
211
1173
JN4AD
NOMESCO Finland
Body CT examination
4.3
14.4
54
132
WX110
NOMESCO Finland
Local anesthesy
1.7
14.3
670
5385
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.9
14.2
90
330
CBB00
NOMESCO Finland
Excision of chalazion
8.2
14.1
31
39
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
13.6
13
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
13.6
13
*
X76
ICPC
Malignant neoplasm breast female
+∞
13.6
13
*
H01.0
ICD-10 Finland
Blepharitis
3.1
13.3
72
240
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
70.7
12.6
14
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.0
12.6
72
248
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
12.6
391
2771
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
12.5
12
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
12.5
12
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
12.5
12
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
131.5
12.5
13
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
12.5
188
1058
A02BC02
ATC
pantoprazole; systemic
1.6
12.0
610
4896
WZC30
NOMESCO Finland
Teaching
2.4
11.9
106
474
S01GX01
ATC
cromoglicic acid; ophthalmic
1.9
11.9
206
1217
ZX090
NOMESCO Finland
Other technic of radiotherapy
47.2
11.9
14
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.9
11.9
38
80
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
11.8
122
586
CD2S4
NOMESCO Finland
Photography of eye
12.7
11.7
20
16
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
65.7
11.6
13
*
L02BB03
ATC
bicalutamide; oral
+∞
11.5
11
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
11.5
11
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
11.5
11
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
11.5
11
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
11.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
11.5
11
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.5
11
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
121.3
11.4
12
*
L02BG03
ATC
anastrozole; oral
121.3
11.4
12
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
10.9
59
198
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.7
10.7
74
289
L03AA02
ATC
filgrastim; parenteral
60.6
10.6
12
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.0
10.5
141
757
N02AX02
ATC
tramadol; systemic, rectal
1.6
10.4
391
2873
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
10.4
10
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
10.4
10
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
10.4
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
H11.8
ICD-10 Finland
Other specified disorders of conjunctiva
16.2
10.4
16
10
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
5.6
10.3
29
53
L02AE02
ATC
leuprorelin; implant, parenteral
8.5
10.1
21
25
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
40.5
10.0
12
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
16.9
9.9
15
9
R03AC02
ATC
salbutamol; inhalant
1.5
9.9
506
3987
N17
ICPC
Vertigo/dizziness
2.1
9.8
117
599
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
6.6
9.8
24
37
ZX120
NOMESCO Finland
Intravenous
2.5
9.7
73
301
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.6
284
1956
L57.0
ICD-10 Finland
Actinic keratosis
2.4
9.4
77
331
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
9.4
9
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
9.4
9
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
9.4
9
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.6
9.3
31
69
XX3DW
NOMESCO Finland
Time consuming IT work
2.8
9.2
58
214
XKD00
NOMESCO Finland
Uroflowmetry
2.0
9.1
128
697
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
37.0
9.0
11
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
18.8
8.9
13
7
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
24.2
8.9
12
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
8.8
264
1818
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.1
8.8
46
151
A98
ICPC
Health maint/preventive medicine
2.2
8.8
982
9240
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.8
8.6
35
95
TQW99
NOMESCO Finland
Other minor procedure on skin
3.2
8.6
43
138
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
5.4
8.5
24
45
A04AD12
ATC
aprepitant; systemic
90.7
8.4
9
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
90.7
8.4
9
*
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
8.3
8
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
8.3
8
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
8.3
8
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
+∞
8.3
8
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
8.3
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.3
8
*
CFD10
NOMESCO Finland
Repair of conjunctiva
+∞
8.3
8
*
L02BG06
ATC
exemestane; oral
+∞
8.3
8
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
8.3
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.3
8
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
8.3
8
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
8.3
8
*
H02AB06
ATC
prednisolone; systemic
1.5
8.3
436
3413
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
8.2
29
69
S21
ICPC
Skin texture symptom/complaint
1.9
8.2
119
660
H11.9
ICD-10 Finland
Disorder of conjunctiva, unspecified
17.3
8.1
12
7
S82
ICPC
Naevus/mole
1.9
8.0
116
641
J01FA10
ATC
azithromycin; systemic
1.5
8.0
537
4404
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
10.9
7.8
14
13
WX402
NOMESCO Finland
General anaesthesia
1.8
7.8
125
716
L29
ICPC
Musculoskeletal sympt/complt other
2.2
7.8
74
344
H10.4
ICD-10 Finland
Chronic conjunctivitis
6.4
7.7
19
30
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
5.3
7.7
22
42
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
7.7
49
183
H11.0
ICD-10 Finland
Pterygium
7.5
7.7
17
23
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
7.6
76
362
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
7.6
374
2870
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
7.5
112
624
J01DB01
ATC
cefalexin; oral
1.5
7.4
783
6976
N02AA05
ATC
oxycodone; systemic
1.9
7.3
99
533
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
7.3
7
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
7.3
7
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
7.3
7
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
7.3
7
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
7.3
7
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
7.3
7
*
B01AB10
ATC
tinzaparin; parenteral
2.7
7.2
46
173
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
7.2
168
1079
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.1
7.1
12
10
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
2.9
7.0
41
147
R4110
NOMESCO Finland
Physiotherapy
1.6
6.9
220
1529
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
6.9
196
1323
B01AB05
ATC
enoxaparin; parenteral
1.5
6.9
243
1730
T15.1
ICD-10 Finland
Foreign body in conjunctival sac
4.8
6.9
21
44
E0000UV
ATC
NA
1.4
6.8
360
2787
L02AE03
ATC
goserelin; implant
11.0
6.8
12
11
TQW20
NOMESCO Finland
Tatoe
40.3
6.8
8
*
D31.1
ICD-10 Finland
Benign neoplasm: Cornea
40.3
6.8
8
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
6.7
319
2417
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
4.3
6.6
23
55
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
6.2
6.5
16
26
ZX080
NOMESCO Finland
Image guided radiotherapy
70.3
6.4
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
70.3
6.4
7
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
70.3
6.4
7
*
KC1GB
NOMESCO Finland
Cystography with X-ray
70.3
6.4
7
*
UJF32
NOMESCO Finland
Coloscopy
1.5
6.3
222
1580
A04AA01
ATC
ondansetron; systemic, rectal
3.1
6.3
32
106
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
1CD02
NOMESCO Finland
NA
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
6.3
6
*
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
6.3
6
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
6.3
6
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
6.3
6
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
6.3
6
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
6.3
6
*
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
+∞
6.3
6
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
6.3
6
*
L02BX02
ATC
degarelix; parenteral
+∞
6.3
6
*
JN4CD
NOMESCO Finland
Very extensive body CT
4.4
6.2
21
49
-50
ICPC
Medication/prescr/renewal
2.5
6.2
45
184
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
6.2
75
389
Z51.5
ICD-10 Finland
Palliative care
3.7
6.2
25
69
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
6.2
86
467
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.4
6.2
17
32
N03AX16
ATC
pregabalin; oral
1.5
6.1
207
1455
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.3
6.1
21
50
H53.1
ICD-10 Finland
Subjective visual disturbances
2.2
6.1
60
284
ZXA10
NOMESCO Finland
Bilateral
1.6
6.1
170
1143
H02.8
ICD-10 Finland
Other specified disorders of eyelid
10.1
6.0
11
11
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
6.0
41
163
N02BE01
ATC
paracetamol; systemic, rectal
1.5
6.0
812
7387
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
119
415
3.08
26.26
4.3
1.5
3.5
3.9
ug/l
0.17
98
320
594
4246
1.81
21.61
6.0
3.7
11.9
11.3
umol/l
0.35
557
3967
666
4943
1.81
21.21
10.1
6.5
3.9
4.2
e9/l
2.52
585
4287
429
2830
1.82
19.96
3.3
2.0
2.4
2.4
mmol/l
0.47
369
2381
841
6851
1.81
18.03
8.4
5.3
76.0
75.0
u/l
0.32
793
6345
502
3621
1.68
16.08
5.2
3.8
35.9
36.0
g/l
0.10
462
3329
516
3879
1.59
13.20
6.5
5.0
1.2
1.2
mmol/l
0.21
463
3451
559
4302
1.57
12.79
7.2
5.5
1.2
1.2
mmol/l
0.30
473
3643
149
803
1.98
12.41
4.1
2.9
235.5
237.1
u/l
0.05
142
754
395
2819
1.61
12.38
3.1
2.7
34.9
31.5
u/l
0.49
376
2694
338
2329
1.64
12.19
4.1
2.9
0.3
0.4
e6/l
0.45
251
1756
293
1953
1.67
12.02
2.3
2.0
—
—
—
0
0
241
1560
1.69
10.94
3.1
2.1
2.5
2.4
mmol/l
1.33
216
1342
722
6018
1.52
10.63
5.5
4.3
42.3
2541.2
e6/l
2.09
15
82
264
1793
1.61
9.81
3.5
2.4
3.6
6.4
e6/l
4.39
234
1561
983
8875
1.68
9.44
15.9
10.6
80.5
81.0
ml/min/173m2
0.26
797
7116
216
1425
1.63
8.97
3.2
2.6
0.8
1.4
e6/l
1.36
124
810
10
10
10.08
8.65
1.7
1.4
—
—
—
0
0
1025
9410
1.73
8.60
17.1
11.8
22.0
22.4
mg/l
0.16
813
7258
486
3876
1.43
8.09
2.4
2.2
82.3
77.0
nmol/l
3.48
428
3428
16
31
5.22
7.94
3.2
2.2
—
—
—
0
0
973
8863
1.59
7.85
5.3
4.7
1.8
2.0
mu/l
0.79
893
8143
146
901
1.71
7.78
3.1
2.3
6.7
7.0
umol/l
0.12
128
765
797
6976
1.45
7.77
4.9
4.1
11.0
11.4
mm/h
0.41
738
6435
715
6142
1.42
7.68
3.3
2.9
46.1
43.9
u/l
0.28
662
5738
1054
9809
1.76
7.67
19.2
14.0
4.0
4.0
mmol/l
0.65
1025
9515
185
1223
1.61
7.55
3.0
2.7
0.8
0.8
mmol/l
0.11
171
1121
1119
10640
2.23
7.31
25.0
17.5
6.7
6.7
e9/l
0.17
1089
10314
1049
9776
1.72
7.24
19.1
13.9
139.7
139.7
mmol/l
0.51
1023
9502
360
2768
1.43
7.11
2.8
2.3
60.7
57.2
u/l
0.23
332
2544
1118
10638
2.19
7.10
24.9
17.5
4.5
4.5
e12/l
0.80
1086
10315
1118
10642
2.18
7.02
25.1
17.6
135.0
136.2
g/l
2.00
1099
10471
1117
10632
2.16
6.96
25.0
17.5
249.5
251.2
e9/l
0.36
1089
10336
624
5287
1.39
6.95
5.1
4.2
6.6
6.7
mmol/l
0.80
581
4875
488
3971
1.39
6.92
4.4
3.6
—
—
—
0
0
110
648
1.77
6.90
2.5
2.2
0.2
0.2
g/l
1.38
105
589
16
36
4.49
6.72
3.2
2.1
24.0
13.1
%
—
10
16
1074
10122
1.76
6.48
12.2
8.7
25.5
25.7
u/l
0.08
1041
9723
340
2629
1.41
6.39
2.8
2.9
1323.5
1308.3
ng/l
0.03
292
2221
435
3511
1.38
6.33
3.9
3.5
42.9
49.3
ng/l
0.13
288
2372
496
4103
1.36
6.14
3.3
2.7
122.6
112.8
ug/l
0.27
460
3784
267
1991
1.44
6.10
1.7
1.7
0.9
1.1
mg/l
1.38
189
1505
475
3914
1.36
5.99
2.2
1.9
96.6
95.4
pmol/l
0.22
239
1974
160
1079
1.56
5.96
2.9
2.5
22.8
23.9
%
0.35
133
919
682
5956
1.35
5.78
3.1
2.9
—
—
—
0
0
91
535
1.76
5.77
1.7
1.6
—
—
—
0
0
823
7401
1.38
5.77
4.3
4.0
14.8
14.8
pmol/l
0.40
743
6750
186
1308
1.50
5.70
3.4
2.8
2.8
2.7
e6/l
0.05
97
698
9
7
12.94
5.58
4.3
1.0
17.4
17.8
u/ml
—
9
7
161
1111
1.52
5.39
2.1
2.2
222.2
130.2
ug/g
0.86
123
875
297
2304
1.39
5.34
2.4
2.1
3.0
2.9
mg/l
0.22
247
1956
117
755
1.61
5.25
2.4
2.2
161.1
40.9
u/l
0.46
95
631
191
1373
1.47
5.24
1.8
1.7
—
—
—
0
0
980
9135
1.45
5.16
4.1
4.0
1.3
1.3
mmol/l
0.37
880
8370
168
1185
1.49
5.06
2.7
2.3
2.4
2.3
g/l
0.30
161
1097
303
2385
1.37
4.94
2.8
2.4
7768.0
6072.7
umol/l
0.22
271
2058
135
916
1.54
4.89
7.1
7.1
0.7
1.3
mmol/l
1.11
109
708
1028
9694
1.50
4.88
5.3
5.0
2.7
2.7
mmol/l
0.38
946
8968
1013
9529
1.48
4.82
4.7
4.4
4.6
4.7
mmol/l
0.44
924
8849
135
919
1.53
4.82
7.0
7.1
5.1
5.1
kpa
0.17
127
884
181
1309
1.45
4.80
2.7
2.3
13.1
13.6
umol/l
0.39
169
1200
857
7844
1.35
4.77
21.4
14.2
13.7
13.6
%
1.39
848
7642
134
919
1.52
4.62
7.0
7.1
12.4
11.9
kpa
0.62
127
884
1005
9456
1.45
4.61
4.6
4.4
1.5
1.5
mmol/l
0.23
915
8734
88
547
1.66
4.60
2.3
2.2
12.2
14.4
nmol/l
1.57
76
485
81
500
1.67
4.36
1.6
1.6
—
—
—
0
0
138
965
1.49
4.34
1.7
1.7
—
—
—
0
0
281
2232
1.34
4.25
1.6
1.5
20.5
21.0
nmol/l
0.24
238
1900
136
961
1.47
4.07
1.7
1.7
—
—
—
0
0
534
4653
1.27
3.97
4.6
3.5
0.0
0.0
estimate
0.80
99
796
525
4581
1.27
3.81
4.6
3.5
0.0
0.0
estimate
0.00
100
812
206
1587
1.36
3.78
3.3
2.6
0.9
0.7
ug/l
0.27
142
1015
990
9365
1.37
3.73
4.9
4.5
5.9
5.9
mmol/l
0.21
902
8531
262
2101
1.32
3.66
1.3
1.3
1.9
1.7
u/ml
0.06
63
570
83
544
1.57
3.55
2.4
3.1
4.3
4.6
pmol/l
2.28
75
469
523
4605
1.25
3.38
5.8
4.7
0.0
0.0
estimate
0.50
103
817
45
254
1.80
3.37
2.2
3.1
—
—
—
0
0
224
1779
1.32
3.34
2.0
1.7
1298.2
1186.9
nmol/l
0.52
165
1340
275
2246
1.29
3.34
4.7
3.6
22.7
24.1
%
0.80
152
991
293
2437
1.27
3.05
5.8
3.8
0.0
0.0
estimate
0.88
103
808
22
100
2.22
3.01
1.3
1.3
—
—
—
0
0
94
658
1.47
2.99
1.9
1.6
65.3
67.4
g/l
2.54
87
592
207
1651
1.31
2.98
1.5
1.5
—
—
—
0
0
31
162
1.94
2.97
1.4
1.5
—
—
—
0
0
340
2888
1.25
2.95
2.1
2.1
194.1
240.5
u/l
0.40
315
2706
329
2785
1.25
2.94
5.5
3.7
5.2
1.9
ug/l
0.77
297
2498
40
228
1.78
2.94
1.5
1.5
299.1
308.3
ug/g
0.11
28
128
92
644
1.47
2.93
2.3
2.4
12.0
19.6
au/ml
—
6
25
35
193
1.84
2.86
2.3
2.1
129.8
131.9
g/l
0.18
25
148
78
531
1.50
2.86
2.8
3.4
1.6
1.9
mmol/l
0.14
55
390
41
240
1.73
2.77
1.6
1.3
—
—
—
0
0
24
118
2.06
2.73
1.3
1.5
—
—
—
0
0
71
479
1.51
2.72
1.1
1.0
—
—
—
0
0
35
197
1.80
2.70
2.0
1.6
—
—
—
0
0
11
37
2.99
2.69
1.3
1.2
198.0
197.8
u/l
0.00
11
37
917
8687
1.26
2.66
19.5
12.9
39.5
40.0
%
0.85
691
6188
26
133
1.98
2.66
1.4
1.4
—
—
—
0
0
31
170
1.85
2.60
1.4
1.5
—
—
—
0
0
30
164
1.85
2.55
5.0
3.5
56.0
58.2
%
0.49
30
164
18
81
2.24
2.54
1.2
1.1
—
—
—
0
0
6
11
5.48
2.54
1.7
2.5
—
—
—
0
0
142
1102
1.33
2.50
6.5
5.0
1.1
1.0
mmol/l
0.81
135
1009
23
116
2.00
2.46
1.3
1.3
—
—
—
0
0
95
694
1.40
2.44
6.5
6.7
8.7
9.8
mmol/l
1.02
90
657
89
645
1.41
2.40
4.6
2.7
1.2
1.2
mmol/l
0.41
83
538
29
161
1.82
2.37
4.7
3.2
4.3
4.4
e9/l
0.05
29
161
928
8839
1.24
2.35
6.3
5.8
39.3
39.9
mmol/mol
1.25
862
8217
202
1663
1.26
2.27
1.3
1.3
31.7
35.9
iu/ml
0.17
60
522
14
60
2.35
2.22
1.2
1.2
—
—
—
0
0
10
36
2.79
2.20
1.3
1.4
—
—
—
0
0
10
36
2.79
2.20
1.3
1.4
—
—
—
0
0
37
226
1.66
2.20
1.1
1.2
—
—
—
0
0
11
42
2.63
2.19
1.5
1.4
—
—
—
0
0
301
2600
1.21
2.16
1.8
1.7
1.4
1.4
mmol/l
0.04
259
2195
41
260
1.60
2.11
1.4
1.9
3.0
5.2
iu/l
1.08
14
91
30
175
1.73
2.11
1.4
1.4
—
15.3
—
0
6
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
207
1.66
2.06
2.7
2.7
0.3
0.4
u/ml
1.43
19
123
7
20
3.51
2.05
1.1
1.3
—
—
—
0
0
84
623
1.38
2.01
1.5
1.2
281.6
241.3
u/ml
0.17
78
572
10
38
2.65
2.01
1.2
1.2
—
—
—
0
0
20
104
1.94
2.01
1.5
1.3
—
—
—
0
0
147
1185
1.28
1.98
30.5
26.8
1.6
1.3
inr
0.92
14
165
16
77
2.09
1.97
1.4
1.6
—
—
—
0
0
31
187
1.68
1.95
3.1
3.0
7.9
8.2
kpa
0.41
31
171
20
106
1.90
1.91
1.7
1.5
0.9
0.4
nmol/l
0.59
11
87
93
709
1.34
1.89
2.0
2.2
69.2
68.1
ml/min/173m2
0.09
33
289
43
286
1.52
1.84
1.7
1.7
—
—
—
0
0
6
17
3.54
1.84
1.2
1.0
51.9
29.7
u/ml
—
6
17
10
40
2.51
1.84
1.1
2.2
—
—
—
0
0
8
29
2.77
1.79
3.0
4.1
—
—
—
0
0
11
47
2.35
1.78
1.1
1.0
—
—
—
0
0
14
67
2.10
1.76
1.0
1.5
—
25.8
—
0
19
9
36
2.51
1.74
1.1
1.2
—
—
—
0
0
9
36
2.51
1.74
1.1
1.2
—
—
—
0
0
238
2054
1.20
1.71
1.7
1.7
50000431.2
35332589.2
pmol/l
0.11
202
1701
105
828
1.29
1.70
2.5
1.9
359.0
360.5
nmol/l
0.02
95
752
27
164
1.66
1.69
2.8
2.5
16.4
16.6
%
0.09
17
84
10
42
2.39
1.68
1.6
2.6
338.6
1182.5
u/ml
—
10
42
23
134
1.73
1.67
1.1
1.2
—
—
—
0
0
91
708
1.31
1.63
4.0
3.7
84.4
86.8
ng/l
0.11
75
618
26
158
1.66
1.63
1.4
1.7
—
—
—
0
0
49
345
1.44
1.62
1.4
1.3
28.7
27.3
iu/l
0.10
39
301
6
20
3.01
1.58
1.0
1.2
—
—
—
0
0
6
20
3.01
1.58
1.0
1.2
—
—
—
0
0
98
776
1.29
1.56
2.7
3.0
204.3
201.7
ng/l
0.02
90
718
8
33
2.43
1.54
2.4
1.3
4.8
5.4
umol/l
—
8
33
10
44
2.28
1.53
1.3
1.3
—
—
—
0
0
34
225
1.53
1.53
3.0
1.3
2.4
1.2
ratio
—
7
24
0
43
0.00
1.52
0.0
1.6
—
—
—
0
0
33
220
1.51
1.45
1.3
1.4
10.3
9.6
u/l
0.12
24
184
43
303
1.44
1.44
1.3
1.3
10.0
10.7
g/l
0.58
38
255
6
22
2.74
1.43
1.2
1.0
—
—
—
0
0
44
312
1.43
1.43
1.3
1.3
3.1
3.1
g/l
0.13
39
239
133
1107
1.23
1.40
1.7
1.8
1.6
1.5
%
0.32
117
970
22
134
1.65
1.39
1.1
1.2
4.1
7.5
u/ml
—
8
58
7
29
2.42
1.39
1.1
1.3
—
—
—
0
0
7
29
2.42
1.39
1.1
1.3
—
—
—
0
0
13
67
1.95
1.38
1.2
1.4
—
—
—
0
0
47
340
1.40
1.38
1.6
1.7
—
—
—
0
0
5
17
2.95
1.36
1.2
1.2
—
—
—
0
0
26
167
1.57
1.35
1.1
1.2
279.7
224.5
u/ml
0.54
20
101
15
83
1.82
1.31
1.4
1.1
2.5
0.8
u/ml
—
8
36
8
34
2.36
1.29
1.3
1.1
—
—
—
0
0
17
99
1.73
1.27
1.5
1.5
—
—
—
0
0
11
55
2.01
1.27
1.4
1.5
—
—
—
0
0
6
25
2.41
1.24
1.3
1.5
—
—
—
0
0
13
70
1.87
1.24
1.8
1.4
0.9
1.0
g/l
1.03
13
70
104
857
1.23
1.22
3.8
2.9
—
—
—
0
0
390
3583
1.13
1.22
5.0
3.6
—
—
—
0
0
65
506
1.30
1.22
1.4
1.5
—
—
—
0
0
27
180
1.51
1.21
1.1
1.2
—
—
—
0
0
26
173
1.51
1.18
1.0
1.3
—
—
—
0
0
26
173
1.51
1.18
1.0
1.3
—
—
—
0
0
12
64
1.88
1.18
1.1
1.2
—
—
—
0
0
14
79
1.78
1.17
1.1
1.4
—
—
—
0
0
167
1450
1.18
1.15
1.5
1.4
—
—
—
0
0
44
331
1.34
1.06
1.3
1.3
3.9
3.9
g/l
0.04
39
236
44
331
1.34
1.06
1.3
1.3
7.4
7.5
g/l
0.12
39
246
44
331
1.34
1.06
1.3
1.3
—
—
—
0
0
37
271
1.38
1.05
1.3
1.2
251.6
247.9
miu/ml
0.02
16
132
181
1595
1.16
1.04
1.4
1.3
15.4
12.6
u/ml
0.19
68
616
98
819
1.21
1.04
2.3
2.4
6.0
7.5
ug/l
0.56
82
717
7
34
2.07
1.03
1.1
1.8
—
1224630.0
—
0
5
9
47
1.92
1.02
1.2
1.1
27.9
17.6
u/l
—
9
41
10
53
1.89
1.01
1.6
2.4
—
—
—
0
0
10
53
1.89
1.01
1.6
1.5
12.4
8.2
u/l
—
5
25
35
257
1.37
0.99
1.1
1.1
0.6
8.5
u/ml
—
5
28
11
188
0.58
0.99
1.7
1.7
—
—
—
0
0
9
49
1.84
0.98
1.2
1.1
77.7
94.8
u/l
—
9
43
21
140
1.51
0.98
1.5
1.5
—
—
—
0
0
42
320
1.32
0.95
1.5
1.6
—
—
—
0
0
20
133
1.51
0.94
1.2
1.3
—
—
—
0
0
7
37
1.90
0.94
2.0
1.9
9.8
238.5
ug/l
—
7
32
30
218
1.39
0.92
1.9
1.7
—
—
—
0
0
34
253
1.35
0.91
1.4
1.3
—
—
—
0
0
48
377
1.28
0.89
1.7
1.7
7.6
4.5
mg/l
0.28
33
270
29
392
0.73
0.88
5.5
3.2
49.9
48.4
%
0.12
29
387
334
3096
1.11
0.88
3.5
3.1
7.1
7.6
mmol/l
1.08
278
2618
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
6
32
1.88
0.82
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
47
1.71
0.80
1.0
1.2
—
—
—
0
0
18
122
1.48
0.80
1.1
1.0
1.5
2.3
u/ml
—
7
57
23
164
1.41
0.80
1.1
1.1
2.4
0.7
u/ml
—
10
68
197
1786
1.12
0.77
3.5
3.7
751.4
397.6
ng/l
0.38
150
1358
37
288
1.29
0.76
1.6
1.6
0.0
0.1
iu/ml
—
6
59
34
262
1.31
0.75
1.4
1.2
—
—
—
0
0
17
116
1.47
0.74
1.3
1.5
—
—
—
0
0
6
106
0.56
0.72
1.5
1.2
—
—
—
0
0
7
39
1.80
0.72
1.0
1.1
106.7
92.7
%
—
7
34
12
76
1.58
0.71
1.3
1.3
—
—
—
0
0
7
40
1.75
0.71
1.7
1.4
—
—
—
0
0
9
57
1.58
0.71
1.4
1.4
—
—
—
0
0
32
247
1.30
0.71
1.4
1.3
—
—
—
0
0
67
565
1.20
0.70
2.5
1.9
—
—
—
0
0
5
27
1.86
0.68
1.0
1.2
—
—
—
0
0
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
27
206
1.32
0.66
1.5
1.4
—
—
—
0
0
27
206
1.32
0.66
1.5
1.4
—
—
—
0
0
27
206
1.32
0.66
1.5
1.4
—
—
—
0
0
27
206
1.32
0.66
1.5
1.4
—
—
—
0
0
133
1192
1.13
0.65
4.4
4.7
31.7
32.5
%
0.29
80
810
134
1202
1.13
0.65
7.1
6.4
—
—
—
0
0
29
225
1.30
0.63
1.8
1.6
7280.1
12149.8
e6/l
0.86
24
172
33
262
1.27
0.61
1.4
1.2
—
—
—
0
0
227
2104
1.10
0.61
5.0
3.8
1.0
1.0
kg/l
0.21
28
302
8
50
1.60
0.61
1.0
1.1
—
—
—
0
0
10
64
1.57
0.58
1.1
1.2
—
—
—
0
0
10
64
1.57
0.58
1.1
1.2
—
—
—
0
0
10
64
1.57
0.58
1.1
1.2
—
—
—
0
0
19
140
1.36
0.58
1.2
1.1
—
—
—
0
0
6
36
1.67
0.56
1.0
1.5
—
—
—
0
0
16
116
1.38
0.54
1.6
1.4
—
—
—
0
0
76
666
1.15
0.54
1.3
1.2
221.9
135.6
iu/ml
0.67
30
274
15
203
0.74
0.52
4.3
2.6
1.4
1.5
mmol/l
0.24
15
195
17
126
1.35
0.51
1.0
1.3
—
0.6
nmol/l
—
0
9
17
126
1.35
0.51
1.1
1.1
—
—
—
0
0
22
170
1.30
0.51
1.2
1.3
—
—
—
0
0
39
324
1.21
0.51
1.8
1.9
—
—
—
0
0
62
539
1.16
0.50
7.5
7.2
25.0
24.4
mmol/l
0.72
57
508
11
76
1.45
0.48
1.0
1.0
327.6
279.6
mg/l
0.90
11
70
11
76
1.45
0.48
2.9
1.2
—
—
—
0
0
16
211
0.75
0.47
1.4
1.6
—
—
—
0
0
7
47
1.49
0.47
1.0
1.1
1036.0
1788.6
miu/ml
—
7
47
53
458
1.16
0.47
2.2
1.8
—
—
—
0
0
22
173
1.28
0.46
1.2
1.6
—
—
—
0
0
11
77
1.43
0.45
1.1
1.1
—
5.6
—
0
5
18
139
1.30
0.43
1.2
1.2
1.0
3.6
u/ml
—
6
43
5
31
1.62
0.43
1.4
1.6
—
—
—
0
0
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
8
58
1.38
0.41
1.6
1.7
—
—
—
0
0
0
15
0.00
0.41
0.0
2.7
—
0.5
—
0
15
5
34
1.47
0.40
2.0
1.2
7.0
9.2
ug/l
—
5
34
5
35
1.43
0.39
3.0
1.4
28.2
29.5
umol/l
—
5
35
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
27
224
1.21
0.38
1.6
1.5
—
—
—
0
0
5
36
1.39
0.38
1.2
1.3
—
—
—
0
0
10
72
1.39
0.37
2.7
1.5
—
—
—
0
0
318
3051
1.06
0.36
4.5
3.9
7.7
8.5
mg/mmol
0.16
207
1918
9
71
1.27
0.36
1.0
1.0
—
—
—
0
0
12
90
1.34
0.36
1.3
1.0
—
—
—
0
0
15
188
0.80
0.33
4.3
2.8
7.3
7.4
mmol/l
0.05
15
181
17
137
1.24
0.32
1.1
1.1
—
—
—
0
0
31
267
1.17
0.31
1.3
1.5
—
—
—
0
0
30
347
0.86
0.31
1.5
1.8
—
—
—
0
0
87
803
1.09
0.30
4.4
3.1
1.7
2.1
mmol/l
0.47
76
641
7
54
1.30
0.30
2.1
1.4
—
—
—
0
0
16
129
1.24
0.30
1.2
1.4
46.5
60.4
%
0.77
11
84
11
84
1.31
0.30
1.1
1.1
—
73.4
—
0
5
54
487
1.11
0.29
1.7
1.3
—
—
—
0
0
16
130
1.23
0.28
1.1
1.1
116.8
116.4
%
0.02
16
120
10
77
1.30
0.26
1.4
1.1
—
—
—
0
0
10
77
1.30
0.26
1.4
1.1
—
—
—
0
0
5
72
0.69
0.26
1.0
1.1
200.4
250.7
mg/l
—
5
63
5
72
0.69
0.26
1.0
1.0
—
—
—
0
0
26
225
1.16
0.26
1.1
1.4
1.9
44.9
e6/l
1.01
19
182
26
225
1.16
0.26
1.1
1.4
136.4
1199.2
e6/l
1.14
20
188
28
245
1.15
0.25
3.1
2.3
147.1
86.7
ug/min
0.29
20
155
11
137
0.80
0.24
1.2
1.1
—
—
—
0
0
10
78
1.28
0.24
1.4
1.1
—
—
—
0
0
10
78
1.28
0.24
1.4
1.1
—
—
—
0
0
10
78
1.28
0.24
1.4
1.1
—
—
—
0
0
27
306
0.88
0.23
1.9
2.2
17421.3
2495.1
u/l
—
7
135
87
816
1.07
0.22
1.6
1.7
—
—
—
0
0
5
42
1.19
0.21
1.8
2.1
49.4
48.2
umol/l
—
5
31
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
17
145
1.17
0.20
3.5
5.1
372.8
370.3
umol/l
0.02
12
125
6
50
1.20
0.19
1.2
1.2
—
—
—
0
0
11
91
1.21
0.17
1.2
1.2
3.2
3.2
ug/l
0.00
11
82
14
162
0.86
0.16
1.2
1.5
—
—
—
0
0
8
72
1.11
0.16
2.0
2.2
—
—
—
0
0
33
303
1.09
0.15
1.4
1.4
—
—
—
0
0
31
284
1.09
0.15
1.7
1.7
2.1
1.5
ug/l
0.16
26
248
27
246
1.10
0.14
1.3
1.1
—
—
—
0
0
35
324
1.08
0.14
1.5
1.5
—
—
—
0
0
11
96
1.15
0.10
1.0
1.1
—
—
—
0
0
14
125
1.12
0.10
1.1
1.0
—
—
—
0
0
5
44
1.14
0.10
1.0
1.4
—
—
—
0
0
10
87
1.15
0.09
3.0
3.8
—
—
—
0
0
5
47
1.06
0.09
2.0
2.1
—
270.5
—
0
11
5
48
1.04
0.09
1.0
1.3
176.6
543.1
u/l
—
5
42
6
57
1.05
0.08
1.3
1.7
2.0
5.5
u/field
—
6
43
5
65
0.77
0.08
1.2
1.2
—
—
—
0
0
91
935
0.97
0.08
2.3
2.0
—
—
—
0
0
10
112
0.89
0.07
3.4
2.4
106.0
105.1
mmol/l
—
10
112
101
1031
0.98
0.06
2.4
2.1
—
—
—
0
0
17
172
0.99
0.00
1.3
1.6
—
—
—
0
0
10
99
1.01
0.00
1.1
1.1
96.5
92.1
%
—
10
92
20
199
1.01
0.00
5.2
3.4
31.5
26.5
mg/l
0.25
12
136
41
413
0.99
0.00
1.5
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
12.0
—
0
6
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
9
93
0.97
0.00
1.2
1.2
—
—
—
0
0
6
66
0.91
0.00
1.2
1.2
—
—
—
0
0
5
58
0.86
0.00
1.2
1.2
—
—
—
0
0
9
90
1.00
0.00
1.2
1.2
—
—
—
0
0
9
93
0.97
0.00
1.2
1.2
—
—
—
0
0
9
89
1.01
0.00
1.2
1.2
—
—
—
0
0
9
93
0.97
0.00
1.2
1.2
—
—
—
0
0
9
90
1.00
0.00
1.2
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONJUNCTIVA_EXALLC – Benign neoplasm: Conjunctiva
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).